Supporting Treatment Access and Recovery in Re-entry (STAR-R)

ConditionsMental Health Substance Use Disorders Co-occurring Mental and Substance Use Disorders

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorUniversity of Massachusetts, Worcester

About this trial

This application is aimed at testing a multicomponent intervention called "Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice (MISSION-CJ) or Peer Linkage Support post-release from two jails in Massachusetts for individuals with co-occurring substance use and mental health disorders (COD), given high rates of COD among incarcerated populations. The research will examine engagement in treatment, behavioral health outcomes, mediators and moderators, an economic analysis, and facilitators and barriers of MISSION-CJ implementation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18 years or older;

Proficient in reading and writing in the English language;

Are released from one of the participating jail/s; and

Have a current co-occurring substance use and mental health disorder, which includes both any substance use disorder (including alcohol) and mental health disorder (including depression, anxiety, trauma related disorders, bipolar, and/or schizophrenia) as documented by the participating jails.

Disqualifiers

Are acutely suicidal based on the CSSRS; or

Are acutely psychotic (as this would require a higher level of care) based on SCID-5-RV.

Trial design

Design model

Parallel

Treatments tested in this trial

Full MISSION-CJ
Behavioral
MISSION-CJ is a time-limited, cross disciplinary, team-based wraparound approach that provides 6 months of psychosocial treatment combined with assertive outreach, empowering clients to access and engage in care and community services to promote recovery and address criminogenic risk. The MISSION-CJ treatment curriculum integrates 3 evidence-based practices: 1) Critical Time Intervention (CTI), a time-limited form of assertive community treatment; 2) Dual Recovery Therapy (DRT), which is integrated mental health and substance use group therapy; and 3) Peer Support (PS), offering support for people in recovery by people in recovery.
Peer Linkage Support
Behavioral
Linkage only is provided via Peer Specialists whom have lived experiences similar to that of our participants. Linkage only includes informal treatment planning and linkages and supports to needed community services.

Treatment groups

240 Participants

are divided into 2 treatment groups

Group A: Full MISSION-CJExperimental treatment 1 intervention

Group B: Peer Linkage SupportActive comparator 1 intervention

Trial outcomes

Primary outcomes

Engagement in Treatment

Measured by total days participating in each condition using fidelity logs adapted for each treatment arm.

Time frame

Measured weekly through 6-months post enrollment

Engagement in Treatment

Measured by total community provider linkages

Time frame

6-months post enrollment

Engagement in Treatment

Measured by total days participating in other healthcare services. Measured using an adapted version of the Treatment Services Review (TSR)

Time frame

Measured at baseline, 3, 6, 9, 12-months post enrollment

Secondary outcomes

Self-reported Substance Use

Measured as self-reported days of use using the Timeline Follow back (TLFB)

Time frame

Measured at baseline, 3, 6, 9, 12-months post enrollment

Overdose Risk

Measured by self-report using the Overdose Risk Questionnaire (OdRi). The OdRi is a 25-item scale scored on a scale between 0 and 25, with greater scores indicating greater risk of overdose.

Time frame

Measured at baseline, 3, 6, 9, 12-months post enrollment.

Overdoses from substances

Measured as self-reported overdoses, and corroborated with surveillance data from the Vitals and MATRIS databases within the Massachusetts Public Health Data Warehouse (MA PHDW)

Time frame

Self reported overdoses measured at baseline, 3, 6, 9, 12-months post enrollment. Surveillance data will be captured in a one time data request from the MA PHDW post-enrollment.

Mental Health Symptoms

Measured by self-reported days of mental health symptoms using the Behavior and Symptom Identification Scale (BASIS-24). This is a 24-item measure scored on a scale of 0 to 4, with greater scores indicating more mental health problems and greater functional impairment.

Time frame

Measured at baseline, 3, 6, 9, 12-months post enrollment

Other outcomes

Mutual Self-Help Group Participation

Measured using the Alcoholics Anonymous Involvement scale (AAI). The AAI is scored dichotomously using 8-items, with minimum scores of 0 and maximum scores of 8, with greater scores indicating greater participation in alcoholics anonymous groups.

Time frame

Measured at baseline, 3, 6, 9, 12-months post enrollment

Mutual Self-Help Group Participation

Measured using the Alcoholics Anonymous Involvement scale (AAI). The AAI also asks about number of AA groups attended, as a continuous measure of attendance.

Time frame

Measured at baseline, 3, 6, 9, 12-months post enrollment

Therapeutic Alliance

Measured using the Working Alliance Inventory (WAI). The WAI is scored on a scale from 36 to 252, with greater scores indicating greater therapeutic alliance.

Time frame

Measured at 3 and 6-months post enrollment

Coping Skills

Measured using the Coping Strategies Scale (CSS). The CSS is scored on a scale of 0 to 69, with greater scores indicating greater use of coping skills.

Time frame

Measured at baseline, 3, 6, 9, 12-months post enrollment

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Massachusetts, Worcester

Lead sponsor

Cornell University

Collaborator

National Institute on Drug Abuse (NIDA)

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: